Literature DB >> 25738018

Left Ventricular Diastolic Dysfunction (LVDD) & Cardiovascular Autonomic Neuropathy (CAN) in Type 2 Diabetes Mellitus (DM): A Cross-Sectional Clinical Study.

Mythri S1, Rajeev H2.   

Abstract

INTRODUCTION: Cardiovascular autonomic neuropathy (CAN) is one of the major complications of Diabetes Mellitus (DM) seen in a significant number of patients, which is often ignored and is also least frequently diagnosed. It can be diagnosed by performing five standard non-invasive bedside autonomic function tests based on Cardiovascular reflexes, which are quite cumbersome. Studies have revealed an increase in mortality in the diabetic patients with CAN due to silent cardiac ischemia, sudden cardiac death, arrhythmias. The precursor of diabetic cardiomyopathy is Left ventricular diastolic dysfunction (LVDD). In the present study we are studying the association between LVDD and CAN, in order to identify high mortality risk patients by performing 2D Echo and looking at LVDD instead of performing the cumbersome bedside cardiovascular autonomic function tests. AIMS AND
OBJECTIVES: To study the association between LVDD and CAN in patients with Type 2 DM.
MATERIALS AND METHODS: This study is a cross-sectional observational study with a sample size of 100. Both outpatients and inpatients between 35 y and 65 y of age with Type 2 DM coming to Department of General Medicine, KIMS hospital, Bangalore were studied from November 2011 to October 2013.Patients with macrovascular complications, Hypertension, congenital & acquired heart diseases etc. were excluded from the study. The standard five autonomic function tests based on cardiovascular reflexes and 2D Echo were performed. Individual scores for each of the five tests were added to produce Ewing's score. Ewing's score of >2.5 is positive for CAN. STATISTICAL ANALYSIS: Chi-square/ Fisher Exact test has been.
RESULTS: There was a significant association between individual non-invasive bedside tests of Ewing's score and LVDD. Significant association was also seen between LVDD and positive Ewing's score.
CONCLUSION: Positive Ewing's score is strongly associated with LVDD in patients with Type 2 DM in this study .This suggests that patients with LVDD have CAN and hence, are at increased risk of sudden cardiac death. As bedside tests are cumbersome, patients with LVDD on 2D Echo can be concluded to have CAN.

Entities:  

Keywords:  Cardiac death; Diabetes mellitus; Ewing’s score; LVDD

Year:  2015        PMID: 25738018      PMCID: PMC4347109          DOI: 10.7860/JCDR/2015/10509.5497

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  17 in total

Review 1.  Diabetic autonomic neuropathy.

Authors:  Aaron I Vinik; Raelene E Maser; Braxton D Mitchell; Roy Freeman
Journal:  Diabetes Care       Date:  2003-05       Impact factor: 19.112

2.  Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study.

Authors:  R M Anjana; R Pradeepa; M Deepa; M Datta; V Sudha; R Unnikrishnan; A Bhansali; S R Joshi; P P Joshi; C S Yajnik; V K Dhandhania; L M Nath; A K Das; P V Rao; S V Madhu; D K Shukla; T Kaur; M Priya; E Nirmal; S J Parvathi; S Subhashini; R Subashini; M K Ali; V Mohan
Journal:  Diabetologia       Date:  2011-09-30       Impact factor: 10.122

3.  A clinical study on autonomic nervous system manifestations in diabetes mellitus.

Authors:  A Goel; Ruchika Agrawal; S Singla; K K Lakhani; D T Sonigra; S B Agarwal
Journal:  J Assoc Physicians India       Date:  2005-11

4.  The value of cardiovascular autonomic function tests: 10 years experience in diabetes.

Authors:  D J Ewing; C N Martyn; R J Young; B F Clarke
Journal:  Diabetes Care       Date:  1985 Sep-Oct       Impact factor: 19.112

Review 5.  Postural hypotension in diabetic autonomic neuropathy: a review.

Authors:  T S Purewal; P J Watkins
Journal:  Diabet Med       Date:  1995-03       Impact factor: 4.359

6.  Incident cases of heart failure in a community cohort: importance and outcomes of patients with preserved systolic function.

Authors:  Maria Ansari; Mark Alexander; Ali Tutar; Barry M Massie
Journal:  Am Heart J       Date:  2003-07       Impact factor: 4.749

7.  Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis.

Authors:  J M Pappachan; J Sebastian; B C Bino; K Jayaprakash; K Vijayakumar; P Sujathan; L A Adinegara
Journal:  Postgrad Med J       Date:  2008-04       Impact factor: 2.401

8.  Independent predictors of cardiac parasympathetic dysfunction in type 2 diabetes mellitus.

Authors:  N K Subbalakshmi; P M R Adhikari; A Rajeev; K Asha; P S Jeganathan
Journal:  Singapore Med J       Date:  2008-02       Impact factor: 1.858

9.  Prevalence of diabetic autonomic neuropathy measured by simple bedside tests.

Authors:  T Dyrberg; J Benn; J S Christiansen; J Hilsted; J Nerup
Journal:  Diabetologia       Date:  1981-03       Impact factor: 10.122

10.  Sample size estimation and power analysis for clinical research studies.

Authors:  Kp Suresh; S Chandrashekara
Journal:  J Hum Reprod Sci       Date:  2012-01
View more
  3 in total

1.  Comorbidity in Adult Patients Hospitalized with Type 2 Diabetes in Northeast China: An Analysis of Hospital Discharge Data from 2002 to 2013.

Authors:  Hui Chen; Yaoyun Zhang; Di Wu; Chunxiu Gong; Qing Pan; Xiao Dong; Yonghui Wu; Kuan Zhang; Shiping Wang; Jianbo Lei; Hua Xu
Journal:  Biomed Res Int       Date:  2016-10-25       Impact factor: 3.411

2.  Cardiovascular Autonomic Neuropathy Is an Independent Risk Factor for Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes.

Authors:  Jiewen Jin; Weimin Wang; Liangying Zhu; Tianwei Gu; Qing Niu; Ping Li; Yan Bi; Dalong Zhu
Journal:  Biomed Res Int       Date:  2017-05-30       Impact factor: 3.411

3.  The Pattern of mRNA Expression Is Changed in Sinoatrial Node from Goto-Kakizaki Type 2 Diabetic Rat Heart.

Authors:  F C Howarth; M A Qureshi; P Jayaprakash; K Parekh; M Oz; H Dobrzynski; T E Adrian
Journal:  J Diabetes Res       Date:  2018-09-02       Impact factor: 4.011

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.